Description

ENROFLOXIN 150 mg – 1 box / 30 tablets
Chemotherapeutic product for dogs and cats.
Ingredients: Active substance – Enrofloxacin hydrochloride 150 mg and excipients – lactose, microcrystalline cellulose, povidone, magnesium stearate, and colloidal silicon dioxide.
Packaging: 30 tablets in blisters, placed in a cardboard box.
Therapeutic indications: For the treatment of gastrointestinal, respiratory, urogenital, and ear infections, pyoderma, prostatitis, arthritis, and osteomyelitis in dogs and cats.
Enrofloxacin hydrochloride is a synthetic chemotherapeutic agent from the fluoroquinolone group and is intended for veterinary use only. It has a wide range of antimicrobial action against gram-negative and gram-positive bacteria and microorganisms. It acts bactericidally in very low concentrations by inhibiting the activity of bacterial DNA Gyrase (subunit A of topoisomerase II). Resistance to Enrofloxacin builds up slowly and is chromosome-type, not plasmid-mediated. It has a long-lasting post-antibiotic effect. It is rapidly and highly absorbed from the digestive tract and distributed in all organs, tissues, and body fluids. It is poorly metabolised and excreted mainly in urine and bile. There is no cross-resistance with chemotherapeutics from other chemical groups. It does not show cumulative properties.
Contraindications: Not to be used in pregnant and lactating bitches and cats, as well as in young dogs less than 8 months in small breeds, less than 12 months in medium breeds, and less than 18 months in large breeds of dogs. Do not give to birds whose eggs are subject to human consumption.
No special precautions are required for the animals for which this product is intended.
Side effects: skin rashes, indigestion (vomiting and diarrhoea), and nervousness (insomnia and anxiety) are rare. The most serious complication is erosive arthropathy in adolescents.
Overdose: This product is very well tolerated. In case of repeated overdose, diarrhoea due to dysbacteriosis in the digestive tract is possible. In such cases, the use of this product is discontinued. There are no special antidotes.
Medicinal or other forms of interaction: do not administer concomitantly with chloramphenicol, macrolide, tetracycline antibiotics, and rifamycins. Products containing magnesium and aluminium compounds make it difficult to absorb this product from the digestive tract.
Species for which this product is intended: Dogs, cats
Dosage: administered orally and individually for each species in the following doses:
– for dogs and cats – 5 mg. / kg. body weight once daily or 2.5 mg/kg. twice a day for 3-5 days

– 1/4 tablet per 7.5 kilograms of body weight

– 1/2 tablet per 15 kilograms of body weight

– 1 tablet per 30 kilograms of body weight

Quarantine period – no. Keep out of reach of children!
Storage: in a dry place and protected from direct sunlight at a temperature below 25˚С.
Additional data on the safety and health protection of people who work with this product are not required.
Special precautions for the disposal of unused veterinary medicinal products (VMPs) are not disposed of via household waste or wastewater. Ask your veterinarian what to do with VMPs that you no longer need.

Expiry date: 08 / 2027